Protocol for Managing Acute Hypertension with Nicardipine (Cardene) Drip
Nicardipine is a first-line intravenous antihypertensive agent for managing acute hypertension, with initial dosing of 5 mg/hr and titration by 2.5 mg/hr every 5-15 minutes to a maximum of 15 mg/hr to achieve target blood pressure. 1
Preparation and Administration
Preparation
- Single dose vials (25 mg) must be diluted with 240 mL of compatible IV fluid to create 250 mL of solution at 0.1 mg/mL concentration 1
- Compatible IV fluids include:
- Dextrose (5%) Injection
- Dextrose (5%) and Sodium Chloride (0.45% or 0.9%) Injection
- Sodium Chloride (0.45% or 0.9%) Injection 1
- Not compatible with Sodium Bicarbonate (5%) or Lactated Ringer's Injection 1
Administration
- Administer via slow continuous infusion through a central line or large peripheral vein 1
- Change infusion site every 12 hours if administered via peripheral vein to minimize risk of venous irritation 1
Dosing Protocol
Initial Dosing
- Start at 5 mg/hr for gradual blood pressure reduction 1
- For more rapid titration in hypertensive emergencies:
Monitoring
- Monitor blood pressure and heart rate continuously during infusion and after discontinuation 1
- Blood pressure begins to fall within minutes of starting infusion
- Reaches approximately 50% of ultimate decrease in about 45 minutes 1
- After discontinuation, 50% offset of action occurs in approximately 30 minutes 1
Target Blood Pressure Goals
Hypertensive Emergency (with target organ damage)
- Reduce SBP by no more than 25% within the first hour 2
- Then, if stable, reduce to 160/100 mmHg within the next 2-6 hours
- Cautiously reduce to normal over the following 24-48 hours 2
Specific Clinical Scenarios
Aortic Dissection:
- Reduce SBP to <120 mmHg within 20 minutes
- Beta-blockade should precede nicardipine administration 2
Acute Renal Failure:
- Nicardipine is a preferred agent 2
Eclampsia/Preeclampsia:
- Nicardipine is appropriate; ACE inhibitors and nitroprusside are contraindicated 2
Acute Coronary Syndromes:
- Nicardipine is one of the preferred agents 2
Acute Ischemic Stroke:
- For patients eligible for thrombolytic therapy with BP >185/110 mmHg:
- Nicardipine 5 mg/hr IV, titrate up by 2.5 mg/hr every 5-15 minutes to maximum 15 mg/hr 2
- During/after thrombolytic therapy:
- Maintain BP ≤180/105 mmHg
- For systolic BP 180-230 mmHg or diastolic BP 105-120 mmHg: Nicardipine 5 mg/hr IV, titrate up to desired effect 2
- For patients eligible for thrombolytic therapy with BP >185/110 mmHg:
Intracerebral Hemorrhage:
- Nicardipine has shown safety and efficacy with low rates of hematoma expansion (3.4%) and neurological deterioration (2.2%) 3
Special Considerations
Impaired Renal Function
- Nicardipine has been shown to be more efficacious than labetalol for acute BP control in patients with renal dysfunction 4
- Use with caution and monitor closely in patients with more than mild renal impairment 1
Impaired Hepatic Function
- Consider lower dosages and monitor response closely
- Use caution in patients with portal hypertension 1
Congestive Heart Failure
- Monitor vital signs carefully, particularly when combined with beta-blockers
- Nicardipine reduces afterload without significantly impairing myocardial contractility 1
Common Pitfalls and Precautions
Avoid too rapid decrease in blood pressure:
- Rapid decreases can lead to organ hypoperfusion
- Particularly important in patients with acute cerebral infarction or hemorrhage 1
Peripheral vein irritation:
- Change infusion site every 12 hours
- Use large peripheral veins or central lines rather than small peripheral veins 1
Reflex tachycardia:
- Monitor heart rate closely
- May increase by approximately 10 beats/minute 5
Drug interactions:
Nicardipine's rapid onset, predictable dose-response relationship, and ease of titration make it an excellent choice for managing acute hypertension in various clinical scenarios.